BioCentury
ARTICLE | Clinical News

Wyeth Lederle regulatory update

March 15, 1999 8:00 AM UTC

The FDA granted fast-track designation to Wyeth Lederle's seven-valent pneumococcal vaccine to prevent invasive pneumococcal disease in children. Wyeth Lederle is a business unit of Wyeth-Ayerst Labo...